Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C106538 |
abacavir |
HLA-B protein affects the susceptibility to abacavir | affects response to substance | 15024131
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of HLA-B mRNA | decreases expression | 15725085 15761015 19128835
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of HLA-B mRNA | decreases expression | 20018196
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of HLA-B mRNA | decreases expression | 15336504
|
D002220 |
Carbamazepine |
HLA-B gene polymorphism affects the susceptibility to Carbamazepine | affects response to substance | 20485159 19915237 18855540 20235791 19694795
|
D002220 |
Carbamazepine |
HLA-B gene SNP affects the susceptibility to Carbamazepine | affects response to substance | 16538176
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of HLA-B mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of HLA-B mRNA | increases expression | 19619570
|
D005436 |
Floxacillin |
HLA-B protein polymorphism affects the susceptibility to Floxacillin | affects response to substance | 19483685
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of HLA-B mRNA | affects cotreatment|increases expression | 17183730
|
C051890 |
irinotecan |
irinotecan analog results in decreased expression of HLA-B mRNA | decreases expression | 18927307
|
C047781 |
lamotrigine |
HLA-B gene polymorphism affects the susceptibility to lamotrigine | affects response to substance | 20235791 20485159
|
C036006 |
oxcarbazepine |
HLA-B gene polymorphism affects the susceptibility to oxcarbazepine | affects response to substance | 20235791
|
D010672 |
Phenytoin |
HLA-B gene polymorphism affects the susceptibility to Phenytoin | affects response to substance | 20235791
|
D012643 |
Selenium |
Selenium results in increased expression of HLA-B mRNA | increases expression | 19244175
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of HLA-B mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of HLA-B mRNA | decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of HLA-B mRNA | increases expression | 20106945
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of HLA-B mRNA | increases expression | 17218384
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of HLA-B mRNA | affects cotreatment|increases expression | 17183730
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of HLA-B mRNA | increases expression | 19101580
|
D014810 |
Vitamin E |
Vitamin E results in increased expression of HLA-B mRNA | increases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Carbamazepine |
20.39 | 8986270 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenytoin |
20.39 | 3425630 9118846 8986270 6195326 9677735 10563481 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
20.39 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
20.39 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.91 | 19490988 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.38 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.38 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.37 | 16835633 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.60 | 15955085 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.23 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.93 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.55 | 17497229 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.06 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.26 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.34 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Phenytoin |
3.91 | 15136057 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.01 | 18177632 18558336 19232924 15238991 16609825 18985861 18775368 20603192 18940202 17507914 19460635 18316065 18396377 17157402 17688650 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.39 | 16935849 |
MESH:D001528 |
Behcet Syndrome |
marker/mechanism |
|
| 20622878 |
MESH:D001714 |
Bipolar Disorder |
|
Carbamazepine |
7.51 | 17594078 20046352 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
7.51 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
15.24 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
15.24 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
15.24 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.79 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.98 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.98 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.82 | 12948864 17261762 17289903 16675129 19861407 18497071 17018787 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.82 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.82 | 16166294 16873071 16443354 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.58 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.31 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.45 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.92 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.78 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.16 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
4.58 | 15553829 16217749 15073043 14691202 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.58 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.58 | 1917145 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.87 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.10 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.28 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.35 | 18670907 18850075 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
abacavir |
5.11 | 18753925 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.08 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.60 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.60 | 18566989 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenytoin |
5.28 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.58 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.70 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.14 | 16835633 |
OMIM:601042 |
CHOREOATHETOSIS/SPASTICITY, EPISODIC |
|
Phenytoin |
5.86 | 11748493 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.16 | 16461808 |
MESH:D002971 |
Cleft Lip |
|
Phenytoin |
4.14 | 2227380 |
MESH:D002972 |
Cleft Palate |
|
Phenytoin |
9.87 | 10789828 6862529 2227380 3877104 6856622 1687470 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
9.87 | 15668235 16354765 12621046 8697196 15340226 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
9.87 | 9407595 |
MESH:D003092 |
Colitis |
|
Selenium |
9.45 | 17936198 |
MESH:D003092 |
Colitis |
|
Tretinoin |
9.45 | 17035595 |
MESH:D003103 |
Coloboma |
|
Phenytoin |
5.13 | 9212184 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
2.59 | 17287894 17725105 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.67 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.67 | 18259882 16391804 17159606 16303861 15273666 18509181 17454858 |
MESH:D000013 |
Congenital Abnormalities |
|
Phenytoin |
9.32 | 10627286 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
9.32 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.17 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
11.80 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Carbamazepine |
11.80 | 9014606 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Phenytoin |
11.80 | 8986270 19952982 9212184 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
11.80 | 15322242 20055451 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
11.80 | 16925845 8800419 10589399 9125849 17551590 14991402 9664655 9211117 9142499 9224671 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
11.80 | 16575769 8888407 17688650 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
11.80 | 19769572 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.08 | 15213294 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.66 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.39 | 19279558 |
OMIM:607208 |
DRAVET SYNDROME |
|
Carbamazepine |
12.36 | 11748493 |
OMIM:607208 |
DRAVET SYNDROME |
|
Phenytoin |
12.36 | 11748493 |
MESH:D003875 |
Drug Eruptions |
marker/mechanism |
|
| 19712599 |
MESH:D003875 |
Drug Eruptions |
|
Phenytoin |
5.49 | 15024534 |
MESH:D004342 |
Drug Hypersensitivity |
marker/mechanism |
|
| 15024131 |
MESH:D004342 |
Drug Hypersensitivity |
|
abacavir |
9.16 | 15024131 15867870 |
MESH:D004342 |
Drug Hypersensitivity |
|
Carbamazepine |
9.16 | 20216337 16538175 15057820 16538176 |
MESH:D056486 |
Drug-Induced Liver Injury |
marker/mechanism |
|
| 19483685 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbamazepine |
12.04 | 17465707 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Floxacillin |
12.04 | 19483685 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
12.04 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
12.04 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
12.04 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Carbamazepine |
8.35 | 20216337 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.35 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.03 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.70 | 9068938 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.36 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.95 | 15322242 16714409 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.95 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Carbamazepine |
9.88 | 17654737 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Phenytoin |
9.88 | 17654737 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.37 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.37 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.00 | 9294722 10568697 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
marker/mechanism |
|
| 16538176 18855540 20235791 20485159 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Carbamazepine |
26.95 | 16415921 20485159 19915237 18855540 16538176 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
lamotrigine |
26.95 | 20235791 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
oxcarbazepine |
26.95 | 20235791 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Phenytoin |
26.95 | 20235791 |
MESH:D004820 |
Epidermolysis Bullosa |
|
Phenytoin |
6.23 | 6251365 1399206 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Carbamazepine |
18.67 | 17275665 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
lamotrigine |
18.67 | 17275665 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
18.67 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Carbamazepine |
24.25 | 16628512 15008574 17116037 |
MESH:D004828 |
Epilepsies, Partial |
|
lamotrigine |
24.25 | 17116037 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenytoin |
24.25 | 17116037 11558140 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
24.25 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Carbamazepine |
20.68 | 17465707 18234410 20417680 7988514 19439326 17178248 19700373 19620853 9014606 821787 |
MESH:D004827 |
Epilepsy |
|
lamotrigine |
20.68 | 19668019 |
MESH:D004827 |
Epilepsy |
|
oxcarbazepine |
20.68 | 17516704 7988514 |
MESH:D004827 |
Epilepsy |
|
Phenytoin |
20.68 | 821787 11434505 20417680 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
20.68 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.57 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Carbamazepine |
19.50 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenytoin |
19.50 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
19.50 | 7750514 |
MESH:D004833 |
Epilepsy, Temporal Lobe |
|
lamotrigine |
6.84 | 16499746 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Carbamazepine |
17.99 | 15276670 3659116 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenytoin |
17.99 | 3659116 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
17.99 | 3659116 |
MESH:D004916 |
Erythromelalgia |
|
Carbamazepine |
5.71 | 19549232 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.44 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.44 | 12903497 |
MESH:D005076 |
Exanthema |
marker/mechanism |
|
| 20485159 |
MESH:D005076 |
Exanthema |
|
Carbamazepine |
5.46 | 20485159 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.78 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.78 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
7.86 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
7.86 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Phenytoin |
10.69 | 10627286 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
10.69 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.89 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.11 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.57 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.57 | 17994277 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.24 | 16904648 |
MESH:D005885 |
Gingival Hyperplasia |
|
Phenytoin |
5.66 | 9029455 |
MESH:D019214 |
Gingival Overgrowth |
|
Phenytoin |
6.23 | 16390469 14659971 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.99 | 17312396 |
MESH:D005910 |
Glioma |
marker/mechanism |
|
| 14511464 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.59 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.17 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.16 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
11.07 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
11.07 | 9664655 14991402 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
11.07 | 16080930 |
MESH:D006333 |
Heart Failure |
|
Selenium |
3.06 | 17162251 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.32 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.88 | 15340226 12621046 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.69 | 16490937 16863852 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.03 | 15709030 |
MESH:D015658 |
HIV Infections |
marker/mechanism |
|
| 17496894 |
MESH:D015658 |
HIV Infections |
|
abacavir |
4.87 | 17457083 11141242 12891065 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
10.05 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
10.05 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.86 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.05 | 8697196 18606429 15340226 16354765 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.19 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.55 | 16778211 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Carbamazepine |
9.85 | 10459572 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Phenytoin |
9.85 | 10459572 |
MESH:D006965 |
Hyperplasia |
|
Carbamazepine |
5.20 | 18773962 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.90 | 18850075 18670907 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.61 | 16612254 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.84 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
10.96 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
10.96 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.95 | 16627594 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.75 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.87 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.87 | 15992940 17551590 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.07 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
6.07 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.87 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
2.96 | 15610895 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
6.31 | 15070760 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.31 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.78 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.30 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.41 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
9.41 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
9.41 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
6.10 | 20471514 16467208 17050201 19850784 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
6.10 | 19850784 16294345 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
6.10 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
7.59 | 17217047 17712046 19035177 17107899 16331271 12712474 15748426 16891316 12018890 16823087 19642359 15622746 19225113 9834237 16330433 17649720 12679006 17869043 11161223 19075265 15336539 16112521 16966277 15213294 11468182 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.59 | 16935935 19035177 17301526 17294898 19029980 17339181 16140955 16823087 17506722 9834237 12679006 17107899 19225113 17712046 17217047 16891316 16331271 17361223 17368321 16788101 15748426 17649720 16766008 19642359 19075265 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.34 | 16882451 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.29 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
4.93 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.93 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
4.93 | 18397230 16248980 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
4.93 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Phenytoin |
3.21 | 14986274 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
4.41 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.41 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
5.76 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.76 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.33 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.16 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.26 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
3.39 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.39 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
3.39 | 11062179 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Carbamazepine |
3.56 | 16628512 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.97 | 11807958 17203775 16891317 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
5.97 | 15318939 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.48 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.78 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.94 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.41 | 16940565 |
MESH:D008607 |
Mental Retardation |
|
Carbamazepine |
6.50 | 9014606 |
MESH:D008607 |
Mental Retardation |
|
Phenytoin |
6.50 | 9212184 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.78 | 15107826 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.17 | 18765137 18803445 |
MESH:D052016 |
Mucositis |
|
irinotecan |
5.00 | 17159606 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.09 | 19417148 14977855 19549372 11468182 15949261 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.01 | 8888407 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.67 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
12.24 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
12.24 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
12.24 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
abacavir |
4.67 | 18753925 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.00 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.26 | 16810080 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenytoin |
5.51 | 17484760 |
MESH:D009224 |
Myotonia Congenita |
|
Carbamazepine |
12.45 | 20399394 |
MESH:D009224 |
Myotonia Congenita |
|
Phenytoin |
12.45 | 1896199 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.94 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
3.16 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.40 | 16946489 16594593 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.72 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Carbamazepine |
23.36 | 16990009 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
23.36 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
23.36 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
23.36 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
17.27 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Phenytoin |
17.27 | 9118846 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
17.27 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
17.27 | 16359493 8888407 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.47 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.72 | 8761367 |
MESH:D010018 |
Osteomalacia |
|
Carbamazepine |
12.45 | 17016548 |
MESH:D010018 |
Osteomalacia |
|
Phenytoin |
12.45 | 17016548 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
7.83 | 19769630 16624393 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
7.83 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.83 | 16936753 |
MESH:D010146 |
Pain |
|
Carbamazepine |
11.46 | 15215642 |
MESH:D010146 |
Pain |
|
Phenytoin |
11.46 | 15215642 |
MESH:D010146 |
Pain |
|
Tretinoin |
11.46 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.26 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.26 | 15976015 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.14 | 19927285 |
MESH:D010267 |
Parapsoriasis |
|
Carbamazepine |
5.69 | 16538176 |
OMIM:167400 |
PAROXYSMAL EXTREME PAIN DISORDER |
|
Carbamazepine |
5.92 | 17145499 17679678 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.25 | 12520081 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.89 | 15087411 |
MESH:D017689 |
Polydactyly |
|
Phenytoin |
5.02 | 9212184 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.54 | 18163543 |
MESH:D011248 |
Pregnancy Complications |
|
Carbamazepine |
5.14 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Carbamazepine |
16.33 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
16.33 | 11118676 11399792 11896295 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
16.33 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.87 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.57 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.57 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.57 | 15084515 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.59 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Carbamazepine |
21.33 | 9591791 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Phenytoin |
21.33 | 8603615 1419762 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
21.33 | 11422049 12752131 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.78 | 16723453 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.82 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
10.80 | 16116481 16283617 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
10.80 | 19155313 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.94 | 16646077 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Carbamazepine |
14.18 | 9046859 15946322 9844417 19414003 16876388 16938433 16180713 |
MESH:D012640 |
Seizures |
|
lamotrigine |
14.18 | 9844417 16499746 |
MESH:D012640 |
Seizures |
|
Phenytoin |
14.18 | 19919933 10029267 3691417 3137016 9844417 11044598 16876388 15946322 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
14.18 | 11044598 15475178 3137016 11738929 14763951 17978042 1511512 16876388 |
OMIM:608579 |
SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO |
marker/mechanism |
|
| 20485159 |
OMIM:608579 |
SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO |
|
lamotrigine |
6.58 | 19668019 20485159 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.44 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
9.37 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.37 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.37 | 16467112 |
MESH:D012893 |
Sleep Disorders |
|
Carbamazepine |
5.11 | 19414003 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.76 | 19490988 |
MESH:D013167 |
Spondylitis, Ankylosing |
marker/mechanism |
|
| |
OMIM:106300 |
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1 |
marker/mechanism |
|
| |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.54 | 12833885 |
MESH:D013262 |
Stevens-Johnson Syndrome |
marker/mechanism |
|
| 15057820 18855540 19694795 19915237 20235791 20485159 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Carbamazepine |
26.49 | 18855540 16538176 15057820 19694795 16415921 19915237 20485159 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
lamotrigine |
26.49 | 20235791 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
oxcarbazepine |
26.49 | 20235791 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Phenytoin |
26.49 | 20235791 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
3.44 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
3.44 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.44 | 17261132 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.50 | 16517955 |
MESH:D013585 |
Synovitis |
marker/mechanism |
|
| |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.90 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
7.15 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.15 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.69 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.77 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.95 | 15213294 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.23 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.21 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.51 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
2.47 | 12845720 20435036 12973940 11780464 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.63 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.66 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.61 | 16752155 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.59 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.04 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.25 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.95 | 16287080 |